Since the announcement about Covaxin data submission by Bharat Biotech for the approval from World Health Organization (WHO), reports have been emerging, predicting the date for the final decision on the Indian Covid -19 vaccine.

According to WHO’s chief scientist Soumya Swaminathan, the agency’s technical advisory group will meet on 26 October to consider granting Emergency Use Listing (EUL) to the vaccine. 

Many people in India are keeping an eye on it because their travel plans are dependent on the WHO's EUL for the vaccine. Young people who have taken Covaxin and want to study abroad are hoping for approval from the UN agency, as numerous nations, notably the United States, have declared they will recognise vaccines approved by the global health body.

Despite the fact that various public health organisations have spoken out against requiring vaccination as a condition of travel, the practice continues in a number of nations, including in Europe.  

Earlier this week, the WHO said on Twitter that it understands that many people are waiting for its recommendation on whether Bharat Biotech's Covid vaccine Covaxin should be added to the EUL, but it can't rush it, adding that it needs more evidence from the Hyderabad-based vaccine maker.